Enanta to appeal as Pfizer wins Paxlovid patent ruling

Enanta Pharmaceuticals (ENTA) announced Tuesday it would appeal a recent U.S. federal court ruling that favored Pfizer (NYSE:PFE) in a patent dispute over the pharma giant’s COVID-19 pill, Paxlovid.

The patent battle between the two started in 2022 when Enanta (